20:42 EST Cathie Wood’s ARK Investment bought 133K shares of Crispr Therapeutics (CRSP) today
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Crispr Therapeutics highlights strategic priorities, anticipated milestones
- Crispr Therapeutics proposes to elect Briggs Morrison to board
- Crispr Therapeutics price target lowered to $85 from $98 at BofA
- Crispr Therapeutics call volume above normal and directionally bullish
- Cathie Wood’s ARK Investment bought 58K shares of Crispr Therapeutics today